Bioforce Nanosciences Holdings, Inc.
BFNH· OTC
Filed Apr 15, 2026 · 10-K · 105 days after period end · 0001091818-26-000047
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$117.80K | -$123.16K | -$114.41K | -$114.74K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioforce Nanosciences Holdings, Inc. · CIK 1310488 · Engraved from SEC EDGAR
ended Dec 31, 2025 · filed Apr 15, 2026 · 105 d after period end